Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIKINASDAQ:DKDCANASDAQ:LUNANASDAQ:ZY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIKIAIkido Pharma$5.27+0.4%$5.24$3.31▼$11.48$28.91M0.9379,326 shs72,855 shsDKDCAData Knights Acquisition$0.55-12.5%$0.42$5.00▼$13.51$2.85M0.1839,705 shs200,027 shsLUNALuna Innovations$0.95+5.0%$0.61$0.22▼$3.39$32.09M1.96193,750 shs11,220 shsZYZymergen$2.43$2.52$1.10▼$12.42$253.58M1.691.23 million shs85 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIKIAIkido Pharma0.00%-5.05%+8.44%+45.18%+180.32%DKDCAData Knights Acquisition0.00%+6.99%+53.06%+13.70%-37.95%LUNALuna Innovations0.00%+5.00%+18.13%+162.50%-68.50%ZYZymergen0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIKIAIkido PharmaN/AN/AN/AN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ALUNALuna Innovations0.1824 of 5 stars0.01.00.00.01.91.70.0ZYZymergenN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIKIAIkido Pharma 0.00N/AN/AN/ADKDCAData Knights Acquisition 0.00N/AN/AN/ALUNALuna Innovations 0.00N/AN/AN/AZYZymergen 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIKIAIkido PharmaN/AN/AN/AN/A$19.27 per shareN/ADKDCAData Knights AcquisitionN/AN/A$0.00 per share111.42($1.82) per shareN/ALUNALuna Innovations$116.61M0.28$0.31 per share3.03N/A∞ZYZymergen$16.74M15.15N/AN/A$3.99 per share0.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIKIAIkido Pharma-$7.17M-$3.88N/AN/AN/AN/A-18.21%-16.94%N/ADKDCAData Knights Acquisition$340K-$0.19N/A∞N/AN/AN/A-5.55%N/ALUNALuna Innovations$9.28MN/A0.00∞N/AN/AN/AN/AN/AZYZymergen-$361.79M-$3.55N/AN/AN/A-2,508.94%-93.37%-61.14%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIKIAIkido PharmaN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/AN/AN/AN/ALUNALuna InnovationsN/AN/AN/AN/AN/AZYZymergenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIKIAIkido PharmaN/A29.5429.54DKDCAData Knights AcquisitionN/AN/AN/ALUNALuna InnovationsN/AN/AN/AZYZymergenN/A4.594.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIKIAIkido Pharma10.88%DKDCAData Knights Acquisition35.35%LUNALuna Innovations87.46%ZYZymergen52.99%Insider OwnershipCompanyInsider OwnershipAIKIAIkido Pharma8.60%DKDCAData Knights Acquisition45.72%LUNALuna Innovations7.60%ZYZymergen11.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIKIAIkido Pharma45.49 million5.01 millionNot OptionableDKDCAData Knights Acquisition25.17 million2.81 millionNot OptionableLUNALuna Innovations39033.96 million31.38 millionOptionableZYZymergen502104.36 million92.15 millionNot OptionableZY, LUNA, AIKI, and DKDCA HeadlinesRecent News About These CompaniesThe California crisis in homeowners insurance has only one real solutionMarch 10, 2025 | msn.comHere's how much Sutter Health just spent on its new 12-acre campus in EmeryvilleFebruary 21, 2025 | bizjournals.comPublic Companies Update – October 2024 One-Minute ReadsNovember 14, 2024 | jdsupra.comThe Role of Massachusetts in Promoting Sustainable Biotech SolutionsOctober 27, 2024 | techbullion.comTOptically Clear Resin Market Forecast: 6.1% CAGR to Drive Industry Growth, Driven by Demand in Electronics and Automotive SectorsOctober 25, 2024 | fmiblog.comFSEC Charges Biotech Co. with Misleading IPO InvestorsOctober 3, 2024 | jdsupra.comSEC Penalizes Company for "Unsupported Hype"September 26, 2024 | jdsupra.comAdvanced Materials (AdMs) in Defense Thematic Intelligence Research ReportSeptember 18, 2024 | finance.yahoo.comArkeaBio: Vaccination is ‘the lowest cost and easiest to scale’ livestock methane reduction solutionSeptember 18, 2024 | agfundernews.comASEC charges Zymergen for “unsupported hype” in its IPOSeptember 18, 2024 | jdsupra.comTroubling Headlines for Emeryville Life Science SectorSeptember 15, 2024 | evilleeye.comEAfter a huge IPO and acquisition, Zymergen caps off bankruptcy with $30M SEC penaltySeptember 13, 2024 | endpts.comESEC Charges Zymergen Inc. With Misleading IPO Investors About Company’s Market Potential and Sales ProspectsSeptember 13, 2024 | msn.comSEC Charges Zymergen Inc. With Misleading IPO Investors About Company's Market Potential and Sales ProspectsSeptember 13, 2024 | newsfilecorp.comNOhmium Announces Enakshi Singh as New Chief Financial OfficerAugust 27, 2024 | sg.finance.yahoo.comZymergen Investors Mostly Advance Claims Against Venture FundsAugust 16, 2024 | news.bloomberglaw.comNGinkgo Bioworks Holdings, Inc. (DNA) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comAI biotechs Exscientia and Recursion agree $688m mergerAugust 8, 2024 | pharmaphorum.comPGenerative AI in Biology Market Size and Trends in 2033May 24, 2024 | pharmiweb.comPGinkgo Bioworks: Broken NarrativeMay 10, 2024 | seekingalpha.comMedia Sentiment Over TimeZY, LUNA, AIKI, and DKDCA Company DescriptionsAIkido Pharma NASDAQ:AIKI$5.27 +0.02 (+0.38%) As of 07/3/2025AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.Data Knights Acquisition NASDAQ:DKDCA$0.55 -0.08 (-12.54%) As of 07/3/2025Data Knights Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. Data Knights Acquisition Corp. was incorporated in 2021 and is based in Frome, the United Kingdom.Luna Innovations NASDAQ:LUNA$0.94 +0.05 (+5.00%) As of 07/3/2025 10:44 AM EasternLuna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.Zymergen NASDAQ:ZYZymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
